Acción FSTX F-STAR THERAPEUTICS, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate
Instrumento Inactivo

Otros idiomas F-star Therapeutics, Inc.

Acciones

FSTX

US30315R1077

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
F-star Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
F-Star Entered into Strategic Collaboration and Licence Agreement with Takeda to Discover and Develop Next-Generationmulti-Specific Antibodies
F-Star Announces Licence Agreement with Takeda for Second Novel Next-Generation Immuno-Oncology Bispecific Antibody
F-star Therapeutics, Inc.(NasdaqCM:FSTX) dropped from S&P TMI Index
F-star Therapeutics, Inc.(NasdaqCM:FSTX) dropped from S&P Global BMI Index
F star Therapeutics : Acquisition/Asset Disposal - Form 8-K
F-STAR THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
F-star Therapeutics Gets Acquired by invoX Pharma for $161 Million
F-star Therapeutics, Inc.(NasdaqCM:FSTX) dropped from NASDAQ Composite Index
InvoX Pharma Completes Acquisition of F-star Therapeutics, Inc.
Sino Biopharmaceutical Completes $161 Million Acquisition of F-star Therapeutics
InvoX Pharma Limited completed the acquisition of F-star Therapeutics, Inc.
F-star Therapeutics Gets Final Regulatory Nod For Acquisition by Invox Pharma
F-star Therapeutics Shares Rally After Cfius Clears Takeover
F-STAR THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
F-star Therapeutics Announces CFIUS Clearance for Proposed Acquisition by invoX Pharma
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
F-STAR THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción FSTX
  4. Noticias F-star Therapeutics, Inc.
  5. Otros idiomas